/
/
/

Bayer CropScience Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021Dec 2020Sep 2020Jun 2020Mar 2020Dec 2019Sep 2019Jun 2019Mar 2019Dec 2018Sep 2018Jun 2018Mar 2018Dec 2017Sep 2017Jun 2017Mar 2017Dec 2016Sep 2016Jun 2016Mar 2016Dec 2015Sep 2015Jun 2015Mar 2015Dec 2014Sep 2014Jun 2014Mar 2014Dec 2013Sep 2013Jun 2013Mar 2013Dec 2012Sep 2012
₹1835 Cr₹1101 Cr₹1106 Cr₹1553 Cr₹1915 Cr₹1046 Cr₹1057 Cr₹1738 Cr₹1631 Cr₹792 Cr₹955 Cr₹1617 Cr₹1740 Cr₹983 Cr₹1038 Cr₹1452 Cr₹1667 Cr₹963 Cr₹990 Cr₹1365 Cr₹1416 Cr₹734 Cr₹918 Cr₹1382 Cr₹1228 Cr₹459 Cr₹854 Cr₹1346 Cr₹950 Cr₹252 Cr₹775 Cr₹1234 Cr₹832 Cr₹300 Cr₹480 Cr₹1232 Cr₹737 Cr₹238 Cr₹695 Cr₹1160 Cr₹856 Cr₹468 Cr₹548 Cr₹1011 Cr₹761 Cr₹570 Cr₹712 Cr₹1241 Cr₹1201 Cr₹553 Cr₹654 Cr₹1050 Cr₹988 Cr₹391 Cr₹588 Cr₹827 Cr
₹89 Cr₹47 Cr₹16 Cr₹14 Cr₹19 Cr₹37 Cr₹32 Cr₹23 Cr₹27 Cr₹29 Cr₹15 Cr₹16 Cr₹21 Cr₹21 Cr₹15 Cr₹14 Cr₹14 Cr₹16 Cr₹10 Cr₹14 Cr₹15 Cr₹16 Cr₹18 Cr₹15 Cr₹15 Cr₹18 Cr₹19 Cr₹10 Cr₹19 Cr₹10 Cr₹16 Cr₹15 Cr₹11 Cr₹6 Cr₹3 Cr₹13 Cr₹16 Cr₹15 Cr₹21 Cr₹14 Cr₹19 Cr₹18 Cr₹15 Cr₹22 Cr₹27 Cr₹22 Cr₹17 Cr₹28 Cr₹21 Cr₹17 Cr₹23 Cr₹28 Cr₹23 Cr₹21 Cr₹12 Cr₹13 Cr
₹1924 Cr₹1147 Cr₹1122 Cr₹1567 Cr₹1933 Cr₹1084 Cr₹1090 Cr₹1761 Cr₹1659 Cr₹821 Cr₹970 Cr₹1633 Cr₹1760 Cr₹1003 Cr₹1053 Cr₹1466 Cr₹1682 Cr₹979 Cr₹1000 Cr₹1379 Cr₹1431 Cr₹750 Cr₹937 Cr₹1396 Cr₹1243 Cr₹477 Cr₹873 Cr₹1357 Cr₹969 Cr₹262 Cr₹791 Cr₹1249 Cr₹843 Cr₹307 Cr₹483 Cr₹1245 Cr₹753 Cr₹253 Cr₹716 Cr₹1174 Cr₹875 Cr₹485 Cr₹562 Cr₹1033 Cr₹789 Cr₹592 Cr₹729 Cr₹1269 Cr₹1222 Cr₹569 Cr₹678 Cr₹1078 Cr₹1011 Cr₹412 Cr₹599 Cr₹840 Cr
₹1518 Cr₹936 Cr₹1004 Cr₹1363 Cr₹1593 Cr₹910 Cr₹1052 Cr₹1568 Cr₹1339 Cr₹711 Cr₹842 Cr₹1324 Cr₹1346 Cr₹804 Cr₹967 Cr₹1229 Cr₹1295 Cr₹784 Cr₹938 Cr₹1158 Cr₹1108 Cr₹673 Cr₹827 Cr₹1098 Cr₹926 Cr₹420 Cr₹709 Cr₹1058 Cr₹763 Cr₹356 Cr₹704 Cr₹1004 Cr₹611 Cr₹325 Cr₹466 Cr₹952 Cr₹630 Cr₹304 Cr₹657 Cr₹929 Cr₹674 Cr₹454 Cr₹510 Cr₹793 Cr₹621 Cr₹525 Cr₹645 Cr₹1002 Cr₹1061 Cr₹495 Cr₹617 Cr₹900 Cr₹878 Cr₹389 Cr₹534 Cr₹689 Cr
₹457 Cr₹250 Cr₹133 Cr₹219 Cr₹367 Cr₹208 Cr₹52 Cr₹208 Cr₹342 Cr₹126 Cr₹143 Cr₹321 Cr₹445 Cr₹227 Cr₹101 Cr₹252 Cr₹409 Cr₹216 Cr₹76 Cr₹236 Cr₹337 Cr₹99 Cr₹124 Cr₹312 Cr₹340 Cr₹76 Cr₹180 Cr₹316 Cr₹220 Cr-₹83 Cr₹99 Cr₹256 Cr₹241 Cr-₹10 Cr₹26 Cr₹301 Cr₹132 Cr-₹43 Cr₹67 Cr₹252 Cr₹208 Cr₹38 Cr₹59 Cr₹246 Cr₹174 Cr₹73 Cr₹90 Cr₹272 Cr₹169 Cr₹85 Cr₹72 Cr₹213 Cr₹141 Cr₹32 Cr₹75 Cr₹161 Cr
₹4 Cr₹6 Cr₹5 Cr₹4 Cr₹5 Cr₹6 Cr₹4 Cr₹3 Cr₹4 Cr₹5 Cr₹3 Cr₹4 Cr₹8 Cr₹7 Cr₹3 Cr₹8 Cr₹4 Cr₹6 Cr₹3 Cr₹2 Cr₹3 Cr₹4 Cr₹4 Cr₹3 Cr₹3 Cr₹3 Cr₹4 Cr₹5 Cr₹3 Cr₹50 L₹4 Cr₹4 Cr₹2 Cr₹2 Cr₹5 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹3 Cr₹4 Cr₹2 Cr₹2 Cr₹2 Cr₹90 L₹80 L₹70 L₹3 Cr₹70 L₹70 L₹60 L₹1 Cr₹1 Cr₹1 Cr
₹402 Cr₹206 Cr₹113 Cr₹200 Cr₹335 Cr₹168 Cr₹34 Cr₹190 Cr₹316 Cr₹105 Cr₹124 Cr₹306 Cr₹406 Cr₹195 Cr₹184 Cr₹229 Cr₹382 Cr₹190 Cr₹118 Cr₹220 Cr₹320 Cr₹80 Cr₹106 Cr₹296 Cr₹313 Cr₹26 Cr₹164 Cr₹216 Cr₹178 Cr-₹95 Cr₹84 Cr₹241 Cr₹230 Cr-₹21 Cr₹12 Cr₹291 Cr₹122 Cr-₹52 Cr₹58 Cr₹243 Cr₹199 Cr₹29 Cr₹49 Cr₹238 Cr₹166 Cr₹64 Cr₹83 Cr₹266 Cr₹160 Cr₹71 Cr₹60 Cr₹178 Cr₹132 Cr₹106 Cr₹1182 Cr₹145 Cr
₹322 Cr₹162 Cr₹96 Cr₹153 Cr₹279 Cr₹143 Cr₹34 Cr₹136 Cr₹254 Cr₹96 Cr₹93 Cr₹223 Cr₹329 Cr₹159 Cr₹135 Cr₹163 Cr₹303 Cr₹153 Cr₹85 Cr₹154 Cr₹254 Cr₹62 Cr-₹45 Cr₹225 Cr₹252 Cr₹32 Cr₹138 Cr₹170 Cr₹135 Cr-₹57 Cr₹63 Cr₹167 Cr₹147 Cr-₹13 Cr₹11 Cr₹191 Cr₹112 Cr-₹36 Cr₹37 Cr₹159 Cr₹131 Cr₹19 Cr₹29 Cr₹156 Cr₹111 Cr₹43 Cr₹55 Cr₹176 Cr₹109 Cr₹46 Cr₹39 Cr₹117 Cr₹88 Cr₹72 Cr₹903 Cr₹98 Cr

Share Price Live Stats

Open (₹)3,960.80
Volume (₹)3,009.00
High (₹)3,989.00
Upper Circuit4,752.90
Low (₹)3,960.80
Lower Circuit3,168.70
Prev Close3,960.80
52W High (₹)5,489.00
Price3,983.90
52W Low (₹)3,935.00

Share Market Cap & Key Ratios Overview

M.Cap (₹)17776.80 Cr
Div. Yield (%)3.79
PE Ratio24.28
Debt to Equity0.00
Price to Book7.04
Book Value660.51
EPS (TTM)162.90
Face Value10.00
ROE (%)23.70

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
PIINDNSE
SUMICHEMNSE
BAYERCROPNSE
SHARDACROPNSE
DHANUKANSE
RALLISNSE
NACLINDNSE
BHAGCHEMNSE
GSPCROPNSE
BHARATRASNSE
LTP
1W Low
1W High
Market cap (₹)
2479.5+59.4 (2.45%)
2353.50
2509
36,261Cr
499.75-18.1 (-3.50%)
495.40
523
24,892Cr
3983.9-64.8 (-1.60%)
3935
4074.40
17,777Cr
775.7-8.05 (-1.03%)
763.40
791.75
6,971Cr
1002.2+26.1 (2.67%)
956
1016
4,488Cr
211.31+1.68 (0.80%)
204.51
213
4,082Cr
167.92-3.71 (-2.16%)
165.21
174.38
3,902Cr
267.65-10.25 (-3.69%)
264.75
285.95
3,462Cr
620.45-6.15 (-0.98%)
597.15
645.95
2,913Cr
1198.8-56.4 (-4.49%)
1179
1259.60
1,970Cr

Key Highlights of Bayer CropScience Ltd’s P&L

In 2006-12-31, Bayer CropScience Ltd reported total revenue of ₹815.68Cr, compared with ₹741.93Cr in 2005-12-31, reflecting Bayer CropScience Ltd turnover.

Depreciation was ₹33.37Cr and finance costs were ₹8.77Cr in 2006-12-31

Profit Before Tax (PBT) has been ₹86.89Cr in 2006-12-31 as compared to ₹76.69Cr in 2005-12-31.

Net Profit (PAT) was ₹55.41Cr in 2006-12-31 compared with ₹38.35Cr in 2005-12-31.

Earnings per share (EPS) were ₹14.03 in 2006-12-31, compared with ₹9.71 in 2005-12-31.